Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,242
Total Claims
$1.7M
Drug Cost
546
Beneficiaries
$3,066
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-93%
Opioid rate vs peers
0.2% vs 2.2% avg
+117%
Cost per patient vs peers
$3,066 vs $1,411 avg
+73%
Brand preference vs peers
18.4% vs 10.6% avg
Opioid Prescribing
0.2%
Opioid Rate
32
Opioid Claims
$442
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 3,539 claims · $1.2M
Generic: 15,675 claims · $444K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 756 | $208K |
| Valbenazine Tosylate | 22 | $163K |
| Pimavanserin Tartrate | 39 | $85K |
| Insulin Glargine,hum.Rec.Anlog | 199 | $69K |
| Dulaglutide | 73 | $61K |
| Insulin Lispro | 163 | $37K |
| Lipase/Protease/Amylase | 18 | $36K |
| Rifaximin | 29 | $35K |
| Brexpiprazole | 46 | $32K |
| Buprenorphine Hcl/Naloxone Hcl | 221 | $30K |
| Insulin Aspart | 92 | $29K |
| Mirabegron | 120 | $27K |
| Cariprazine Hcl | 36 | $24K |
| Empagliflozin | 80 | $23K |
| Divalproex Sodium | 301 | $21K |
Prescribing Profile
Patient Profile
73
Avg Age
53%
Female
2.72
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data